This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Nonalcoholic Steatohepatitis
and you are
between 18 and 75
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The AURORA study will be conducted to confirm the efficacy and safety of cenicriviroc (CVC) for the treatment of liver fibrosis in adult subjects with NASH.

Provided treatments

  • Drug: Cenicriviroc
  • Drug: Placebo
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028740. The sponsor of the trial is Tobira Therapeutics, Inc. and it is looking for 2000 volunteers for the current phase.
Official trial title:
AURORA: A Phase 3 Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis